Although endometrial carcinoma is one of the most common gynecological malignancies worldwide. its precise etiology remains unknown. Moreover. no novel adjuvant and/or targeted therapies are currently being developed to achieve greater efficacy for endometrial cancer patients who develop chemotherapeutic drug resistance. https://www.nacrack.com/deal-alert-Dea-Eyewear-Jemma-deal-zone/